Kiniksa Pharmaceuticals International, plc (KNSA) SEC filings and CIK.
KNSA’s SEC Central Index Key (CIK) is 0001730430, or 1730430 without leading zeros. The SEC’s ticker file lists it as Kiniksa Pharmaceuticals International, plc.
- Ticker
- KNSA
- CIK
- 0001730430
- Other tickers
- None
- Insider transactions, Q3 2026
- 36
Insider trading
In Q3 2026, insiders at Kiniksa Pharmaceuticals International, plc reported 36 non-derivative transactions on 11 Forms 3, 4 and 5, including 0 open-market purchases and 2 sales. See every KNSA insider transaction →
Recent filings we observed
| Filed | Form | Accession |
|---|---|---|
| 2026-11-06 | 4 | 0001532218-26-000020 |
Get KNSA SEC data through the API
curl "https://sec-api.dev/api/v1/filings?cik=1730430&limit=10" \
-H "Authorization: Bearer $SEC_API_KEY"curl "https://sec-api.dev/api/v1/companies/1730430" \
-H "Authorization: Bearer $SEC_API_KEY"curl "https://sec-api.dev/api/v1/facts/1730430?taxonomy=us-gaap&concept=Revenues&limit=10" \
-H "Authorization: Bearer $SEC_API_KEY"Ticker to CIK API · SEC filings API · Kiniksa Pharmaceuticals International, plc on SEC.gov
Questions
What is KNSA’s CIK number?
KNSA’s SEC Central Index Key (CIK) is 0001730430, or 1730430 without leading zeros. The SEC’s ticker file lists it as Kiniksa Pharmaceuticals International, plc.
How do I find Kiniksa Pharmaceuticals International, plc’s 10-K?
Request /api/v1/filings?cik=1730430&form=10-K, or open the company’s EDGAR page and filter by 10-K. Foreign issuers file 20-F or 40-F instead.
Plain-text version for agents and LLMs: /companies/knsa.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.